Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $31.9M invested in Corvus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $34.2M → $31.9M (-$2.36M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
47
Holding in Top 10
1
Calls
$79K
Puts
$73K
Top Buyers
| 1 | +$254K | |
| 2 | +$134K | |
| 3 | +$92.8K | |
| 4 |
Renaissance Technologies
New York
|
+$88.3K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$39.7K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$434K | |
| 3 | -$263K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$205K |
| 5 |
Two Sigma Investments
New York
|
-$139K |